Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions.
about
Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Inhibition of B7-1 (CD80) by R ...... human atherosclerotic lesions.
@en
Inhibition of B7-1
@nl
type
label
Inhibition of B7-1 (CD80) by R ...... human atherosclerotic lesions.
@en
Inhibition of B7-1
@nl
prefLabel
Inhibition of B7-1 (CD80) by R ...... human atherosclerotic lesions.
@en
Inhibition of B7-1
@nl
P2093
P2860
P356
P1476
Inhibition of B7-1 (CD80) by R ...... human atherosclerotic lesions.
@en
P2093
Andreas O Doesch
Christian A Gleissner
Christian Erbel
David Rohde
Deniz Okuyucu
Hugo A Katus
Maani Hakimi
Mohammadreza Akhavanpoor
Thomas J Dengler
P2860
P304
P356
10.2147/DDDT.S59594
P407
P577
2014-05-12T00:00:00Z